A 46-year-old woman previously diagnosed as having systemic lupus erythematosus pre sented with severe hypoalbuminemia and anasarca. She was demonstrated to have protein-losing enteropathy without any other active symptoms of SLE. Her bowel habit was normal and endoscopic examination revealed non-specific colitis and a small ulcer in the duodenum. Serum biochemistry showed an abnormal profile of the serum protein, including severe hyperlipopro teinemia and hyperfibrinogenemia. The process of protein-losing was not selective in terms of the molecular size. All of these symptoms and the abnormalities in laboratory data were improved by corticosteroid therapy. (Internal Medicine 31: 521-524, 1992) Key words: hypoalbuminemia, hyperlipoproteinemia, corticosteroid therapy Case Report A 46-year-old woman was referred for investigation of severe hypoalbuminemia and anasarca. Twelve years previously, systemic lupus erythematosus (SLE) was diagnosed by her local doctor when she presented with Raynaud's phenomenon, photosensitivity, low grade fever, easy fatigability, polyarthralgia, butter fly rashes and a positive anti-nuclear antibody. Her symptoms settled with low doses of prednisolone and cyclophosphamide. One year later she developed edema in the lower extremities, which was found to be caused by excessive proteinuria. She was successfully treated with an increased dose of prednisolone. Thereafter with tapering doses of prednisolone, she remained well until two years before admission when hypoalbuminemia and systemic edema gradually developed. Diagnosis of Cushing's syndrome due to long-term corticosteroid therapy was made and the dose of prednisolone was reduced to 2.5 mg, resulting in further deterioration of hypoalbuminemia and systemic edema. Six months before admission she was suspected of having protein-losing enteropathy (PLE) because no other cause of protein loss was detected. Upper gastrointestinal endoscopy, barium enema, and colonofiberscopy revealed no visible abnormalities. When treated with an increased dose of prednisolone, she developed systemic itchy small papules, which were thought to be elicited by an allergic reaction to an ingredient in the prednisolone tablets. The regimen of prednisolone was switched to that of low dose dexamethasone with disappearance of the rashes. Hypoalbuminemia and edema, however, worsened further, requiring the administration of albumin and diuretics. She had become divorced 12 years before and had no children. Her father died of acute myocardial infarction, and her mother suffered from hypertension. On admis sion she had normal vital signs. Her height was 152cm and weight 46.5kg. Physical examination revealed pigmentation of the bilateral cheeks and the upper part of the back, moon face and pitting edema in the extremities. No lymphadenopathy was present. Chest, abdominal and neurological examination revealed no abnormalities. Major findings of laboratory study were the following: hematocrit, 38%; white-cell count, 5,300/mm3 with a normal differential count; platelet count, 280,000/mm3; prothrombin time, 100% ; partial thromboplastin time, 81%; fibrinogen, 755mg/dl; total protein, 3.9g/dl; albumin, 1.8g/dl; serum electrophoresis, decreased albumin fraction, increased alpha 1 and 2 globulin fractions; total cholesterol, 458mg/dl; triglyceride,
symptoms settled with low doses of prednisolone and cyclophosphamide. One year later she developed edema in the lower extremities, which was found to be caused by excessive proteinuria. She was successfully treated with an increased dose of prednisolone. Thereafter with tapering doses of prednisolone, she remained well until two years before admission when hypoalbuminemia and systemic edema gradually developed. Diagnosis of Cushing's syndrome due to long-term corticosteroid therapy was made and the dose of prednisolone was reduced to 2.5 mg, resulting in further deterioration of hypoalbuminemia and systemic edema. Six months before admission she was suspected of having protein-losing enteropathy (PLE) because no other cause of protein loss was detected. Upper gastrointestinal endoscopy, barium enema, and colonofiberscopy revealed no visible abnormalities. When treated with an increased dose of prednisolone, she developed systemic itchy small papules, which were thought to be elicited by an allergic reaction to an ingredient in the prednisolone tablets. The regimen of prednisolone was switched to that of low dose dexamethasone with disappearance of the rashes. Hypoalbuminemia and edema, however, worsened further, requiring the administration of albumin and diuretics. She had become divorced 12 years before and had no children. Her father died of acute myocardial infarction, and her mother suffered from hypertension. On admis sion she had normal vital signs. Her height was 152cm and weight 46.5kg. Physical examination revealed pigmentation of the bilateral cheeks and the upper part of the back, moon face and pitting edema in the extremities. No lymphadenopathy was present. Chest, abdominal and neurological examination revealed no abnormalities. Major findings of laboratory study were the following: hematocrit, 38%; white-cell count, 5,300/mm3 with a normal differential count; platelet count, 280,000/mm3; prothrombin time, 100% ; partial thromboplastin time, 81%; fibrinogen, 755mg/dl; total protein, 3.9g/dl; albumin, 1.8g/dl; serum electrophoresis, decreased albumin fraction, increased alpha 1 and 2 globulin fractions; total cholesterol, 458mg/dl; triglyceride, From the Fourth Department of Internal Medicine, the University of Tokyo Faculty of Medicine, Tokyo Received for publication August 6, 1991 revealed sick euthyroid syndrome with free T4 of 0.5 ng/dl, T3 of 60 ng/dl, TSH of 2.2 //U/ml, and thyroxine binding globulin of 15 jdg/dl; stool occult blood, positive by Guaiac test; urine sedimentation, within normal limits; 24-hour urinary protein, 231mg; serological test for syphilis, negative; anti-DNA antibody, positive at a dilution of 1:80; anti-ENA antibody, positive at a dilution of 1:50. Chest and abdominal X-ray studies were within normal limits. Her electrocardiogram was normal. Abdominal echosonography revealed mild ascites and thickening of the wall of the gall bladder. Thyroid echo sonogram showed a normal pattern. Due to the fact that the level of the loss of protein in the urine was non-nephrotic and there was no evi dence of increased protein catabolism, protein-losing enteropathy was strongly suspected. A 24-hour alpha 1-antitrypsin stool clearance study was performed, showing an increased clearance of 144ml/day (normal, less than 13 ml/day). Upper gastrointestinal endoscopy proved no enlargement of gastric folds. Colonofiberscopy showed non-specific colitis. Biopsy of the colonic mucosa revealed Paneth cell metaplasia suggesting long-term ischemia or inflammation. Endoscopy of the small intes tine showed a small ulcer in the second portion of the duodenum. There was no steatorrhea nor diarrhea. Culture of her stool revealed normal flora. Scintigraphy with 99mTc-labelled albumin failed to detect any active bleeding or protein-losing site in the gastrointestinal tract. Investigation of her hyperlipoproteinemia revealed the following: lipoprotein fractions after 14-hour fasting, LDL 1,755mg/dl, VLDL 394mg/dl, chylomicron 36mg/dl; apolipoprotein fractions, decreased A-l and A-2, increased B, C-2, C-3 and E. Other results of the serum protein measurements: prealbumin 14.3 mg/dl, ceruloplasmin 35.2mg/dl (normal, 21-33), alpha-1 antitrypsin 270 mg/dl, retinol binding protein 3.4 mg/dl, alpha-2-macroglobulin 670mg/dl (normal, 186-277), haptoglobin 583mg/dl (normal, 96-350), beta-2 microglobulin 4,681 /ig/1 (normal, 500-2,000). PLE probably due to SLE was diagnosed and ther apy with an increased dose of dexamethasone (5mg) was started. As the hypoalbuminemia and hyperlipo proteinemia deteriorated further, the regimen was changed to high-dose betamethasone (10mg). Four weeks later she gradually began to recover with an molecules as is the case with nephrotic syndromes. We failed to locate directly the site of protein-losing by the radionuclide-imaging method, although non specific colitis and a duodenal ulcer were found which were believed to be elicited by broadly distributed angitis and ischemia. In a few former reports, mucosal lymphangiectasia and venulitis were detected in the biopsy specimens of the gastrointestinal tract. In most of those cases, however, nothing remarkable was found which could be responsible for the process of protein losing in the gastrointestinal tract. The characteristics of the 18 previously reported cases and of the present case are summarized in Table 1 . Eighty-nine percent of them are women, while the ratio of women in SLE is about 90%. Mean age of onset ofPLE is 31 years old. All the patients have hypoalbuminemia and more than 70% of them show hyperlipoproteinemia, which is entirely different from PLE in other diseases, such as Crohn's disease which is almost always associated with diarrhea and malabsorption. It is notable that 21% of the cases suffered also from Hashimoto's thyroiditis, while Hashimoto's thyroiditis is infrequently associated with SLE (19) . Those cases without hyperlipoproteinemia consistently suffer from diarrhea and those cases with out diarrhea unexceptionally developed hyperlipopro teinemia. This leads us to a speculation that an association of hyperlipoproteinemia in a patient with PLE depends mainly on the existence of diarrhea, which might be a sign of another pathologic process occurring con comitantly in the gastrointestinal tract. Thus we can classify PLE in SLE into two subentities in terms of the existence of diarrhea. The mechanism how PLE in SLE elicits hyperlipoproteinemia remains to be clarified.
On one hand, the nature of the intestinal lesions seems to determine whether hyperlipoproteinemia occurs, because a case with lymphangiectasia of the ileum (7) and a case with vasculitis in the jejunum (6) show normo and hyperlipoproteinemia, respectively. On the other hand, we speculate that the generation of hyperlipo proteinemia may also depend on the location of the gastrointestinal lesions. Cases with Crohn's disease and resultant PLE typically show hypoalbuminemia without hypercholesterolemia, in which the main site of gastrointestinal lesions is in the small intestine and malabsorption is elicited, while in all the cases with PLE in SLE investigated in that respect steatorrhea was not found. Since most of the cases, however, did not undergo full gastrointestinal study, the details of the gastrointes tinal lesions are not clear.
In conclusion, we report here a patient with severe hypoalbuminemia and hyperlipoproteinemia due to PLE in fairly well-controlled SLE. Large-dose corti costeroid therapy improved abnormal serum biochemical parameters including hypoalbuminemia and hyperlipo proteinemia. The responsible intestinal lesions are thought to be angitis and resultant ischemia mainly in the large intestine and the large part of the small intestine is presumably well spared because the patient had hyper lipoproteinemia and no malabsorption.
